Annals of Surgery · 2022 · 43 citations · 76 references
MedicinePlastic SurgerySurgeryLymphedema SurgeryTransplant SurgeryVascular SurgeryComplications Of Lymphedema SurgeryDonor Site MorbidityLymphedema ManagementTransplant ComplicationsTransplant OutcomesVascularized Lymph Node TransferBioimpedance MeasurementGroin Lymph Node TransferLymph Node TransplantationLymphedema Volume ReductionOmental Lymph Node TransferOutcome MeasuresPatient-reported Outcome MeasurementSupraclavicular Lymph Node Transfer
PURPOSE: While vascularized lymph node transplant (VLNT) has gained popularity, there are a lack of prospective long-term studies and standardized outcomes. The purpose of this study was to evaluate the safety and efficacy of VLNT using all available outcome measures. METHODS: This was a prospective study on all consecutive patients who underwent VLNT. Outcomes were assessed with 2 patient-reported outcome metrics, limb volume, bioimpedance, need for compression, and incidence of cellulitis. RESULTS: There were 89 patients with the following donor sites: omentum (73%), axilla (13%), supraclavicular (7%), groin (3.5%). The mean follow-up was 23.7±12 months. There was a significant improvement at 2 years postoperatively across all outcome measures: 28.4% improvement in the Lymphedema Life Impact Scale, 20% average reduction in limb volume, 27.5% improvement in bioimpedance score, 93% reduction in cellulitis, and 34% of patients no longer required compression. Complications were transient and low without any donor site lymphedema. CONCLUSIONS: VLNT is a safe and effective treatment for lymphedema with significant benefits fully manifesting at 2 years postoperatively. Omentum does not have any donor site lymphedema risk making it an attractive first choice.
76
Lymphoedema: an underestimated health problem
Christine Moffatt, Peter Franks, Debra Doherty et al. · QJM · 2003 · 560 citations · Full text